217 related articles for article (PubMed ID: 36195187)
1. Anticancer peptides mechanisms, simple and complex.
Norouzi P; Mirmohammadi M; Houshdar Tehrani MH
Chem Biol Interact; 2022 Dec; 368():110194. PubMed ID: 36195187
[TBL] [Abstract][Full Text] [Related]
2. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
3. Chemical Strategies towards the Development of Effective Anticancer Peptides.
Li C; Jin K
Curr Med Chem; 2024; 31(14):1839-1873. PubMed ID: 37170992
[TBL] [Abstract][Full Text] [Related]
4. Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
Alamdari-Palangi V; Jaberi KR; Shahverdi M; Naeimzadeh Y; Tajbakhsh A; Khajeh S; Razban V; Fallahi J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15249-15273. PubMed ID: 37581648
[TBL] [Abstract][Full Text] [Related]
5. Anti-Cancer Peptides: Status and Future Prospects.
Ghaly G; Tallima H; Dabbish E; Badr ElDin N; Abd El-Rahman MK; Ibrahim MAA; Shoeib T
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770815
[TBL] [Abstract][Full Text] [Related]
6. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).
Chiangjong W; Chutipongtanate S; Hongeng S
Int J Oncol; 2020 Sep; 57(3):678-696. PubMed ID: 32705178
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptides with anticancer activity: Today status, trends and their computational design.
Kordi M; Borzouyi Z; Chitsaz S; Asmaei MH; Salami R; Tabarzad M
Arch Biochem Biophys; 2023 Jan; 733():109484. PubMed ID: 36473507
[TBL] [Abstract][Full Text] [Related]
8. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of anticancer peptides (ACPs) from amphibian origin.
Oelkrug C; Hartke M; Schubert A
Anticancer Res; 2015 Feb; 35(2):635-43. PubMed ID: 25667440
[TBL] [Abstract][Full Text] [Related]
10. DCTPep, the data of cancer therapy peptides.
Sun X; Liu Y; Ma T; Zhu N; Lao X; Zheng H
Sci Data; 2024 May; 11(1):541. PubMed ID: 38796630
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design for binding peptides in anti-cancer therapy.
Wang SH; Yu J
Biomaterials; 2018 Feb; 156():1-15. PubMed ID: 29182932
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evidence on the Anticancer Properties of Food Peptides.
Rajendran SR; Ejike CE; Gong M; Hannah W; Udenigwe CC
Protein Pept Lett; 2017; 24(2):126-136. PubMed ID: 27538700
[TBL] [Abstract][Full Text] [Related]
13. In Silico Design of Anticancer Peptides.
Kumar S; Li H
Methods Mol Biol; 2017; 1647():245-254. PubMed ID: 28809008
[TBL] [Abstract][Full Text] [Related]
14. De novo design of anticancer peptides by ensemble artificial neural networks.
Grisoni F; Neuhaus CS; Hishinuma M; Gabernet G; Hiss JA; Kotera M; Schneider G
J Mol Model; 2019 Apr; 25(5):112. PubMed ID: 30953170
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.
Xie M; Liu D; Yang Y
Open Biol; 2020 Jul; 10(7):200004. PubMed ID: 32692959
[TBL] [Abstract][Full Text] [Related]
16. Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.
Aronson MR; Simonson AW; Orchard LM; Llinás M; Medina SH
Acta Biomater; 2018 Oct; 80():269-277. PubMed ID: 30240951
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides.
Zhao Y; Wang S; Fei W; Feng Y; Shen L; Yang X; Wang M; Wu M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073203
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Computational Methods for Identifying Anticancer Peptides.
Feng P; Wang Z
Curr Drug Targets; 2019; 20(5):481-487. PubMed ID: 30068270
[TBL] [Abstract][Full Text] [Related]
19. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.
Bakare OO; Gokul A; Wu R; Niekerk LA; Klein A; Keyster M
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439786
[TBL] [Abstract][Full Text] [Related]
20. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.
Hong ST; Lin H; Wang CS; Chang CH; Lin AM; Yang JC; Lo YL
J Nanobiotechnology; 2019 Aug; 17(1):89. PubMed ID: 31426807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
